Clinical Trials Browser

Phase 3 × lifileucel × Dermatologic × Clear all

NCT05727904 2025-07-08

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Phase 3 Recruiting

Melanoma, Skin Neoplasms